- The trend backdrop is active with a 12-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
CRDL
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Cordel Group Plc · Technology · Software - Application
Latest close
0.12 GBP
0.4%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 49.1% above the Trend Line and sits at 98.8% of its 52-week range. The latest completed week returned 0.4%, after a 1.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.
Setup score
48
out of 100
Latest Close
0.12 GBP
7 Aug 2026
1W Return
0.4%
latest completed week
4W Return
1.2%
short-term follow-through
12W Return
5.6%
quarterly tape
Trend Breadth
23.1%
12 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- Next-week expectancy is negative at 26.80% based on similar historical setup states.
- 3 reversal markers appear in the recent smart-money tape.
- Recent volatility is running well above the one-year baseline.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.4%
Latest completed week; four-week move 1.2%.
Indicator stack
54/52
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 26.80%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
8 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 49.1% above the Trend Line and sits at 98.8% of its 52-week range. The latest completed week returned 0.4%, after a 1.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9712-week average 0.74
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.97Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.2% over four weeks, 5.6% over 12 weeks, and 89.2% over one year. The current trend has remained active for 12 consecutive weeks.
Performance by holding period
Active trend streak12 weeks
Active weeks in one year12
Trend breadth23.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.33Latest activity-pressure read.
Pressure change-47.1%Four-week change in activity pressure.
Leadership52.26Latest relative-leadership reading.
RS change-16.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 67%
Model confidence 53%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength70/100Blend of value, momentum, and quality. Underlying universe rank 31; rank 1 is best.
Value64/100Relative valuation strength. Underlying universe rank 37; rank 1 is best.
Quality65/100Profitability and accounting quality. Underlying universe rank 36; rank 1 is best.
Momentum66/100Medium-term price momentum. Underlying universe rank 35; rank 1 is best.
Growth66/100Revenue and earnings growth. Underlying universe rank 35; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.1x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -113.9% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 73.7% Gross profit retained from each unit of revenue.
- Operating margin
- -6.7% Operating profit retained from revenue.
- Free-cash-flow margin
- -6.3% Free cash flow generated from revenue.
- Return on invested capital
- -18.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 7.9% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- - Net share repurchases relative to market value.
- Shareholder yield
- - Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 5.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 8 relevant articles.
0 positive · 8 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.8%Distance below the 52-week high.
13-week volatility25.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 261 weeks finished lower.
Best week+94.2%Week of 15 May.
Worst week-6.2%Week of 20 Feb.
Latest week+0.4%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains7
Flat weeks14
Modest losses0
Sharp losses1
Recent vol25.0%13-week weekly-return volatility.
Base vol13.7%52-week weekly-return volatility.
Up/down split19/12Count of positive and negative weeks in the 52-week window.
Average skew8.8% / -5.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Technology
4-week rank49 / 100
Group average2.8%
Trend breadth37.0%
Trend37.0%active weekly trend signals
MD58.0%positive activity pressure
RS34.0%positive relative leadership
Four-week leaders
IndustryGB Software - Application
4-week rank24 / 52
Group average2.3%
Trend breadth23.1%
Trend23.1%active weekly trend signals
MD61.5%positive activity pressure
RS17.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape48/100
Trend, activity pressure, participation, and risk combine to a 48/100 tape read.
Indicator analysis85/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.97; 3 reversal markers Next-Week ExpectancyNegative 26.80%Next-week expectancy is negative with a 26.80% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors65/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 50 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 8 relevant articles.
Cardiol Therapeutics Inc (CRDL) Earnings Forecast: Future EPS & Revenue Growth Estimates Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.12 GBP | 0.4% | 0.08 GBP | 0.06 GBP | 0.33 | 52.26 | 797.0K | On |
| 31 Jul 2026 | 0.12 GBP | 0.0% | 0.08 GBP | 0.06 GBP | 0.43 | 53.75 | 94.6K | On |
| 24 Jul 2026 | 0.12 GBP | 0.8% | 0.08 GBP | 0.06 GBP | 0.51 | 57.28 | 323.7K | On |
| 17 Jul 2026 | 0.12 GBP | 0.0% | 0.08 GBP | 0.06 GBP | 0.57 | 59.75 | 380.0K | On |
| 10 Jul 2026 | 0.12 GBP | 0.0% | 0.07 GBP | 0.06 GBP | 0.62 | 62.85 | 697.8K | On |
| 3 Jul 2026 | 0.12 GBP | 2.1% | 0.07 GBP | 0.06 GBP | 0.67 | 61.60 | 108.4K | On |
| 26 Jun 2026 | 0.12 GBP | 0.0% | 0.07 GBP | 0.06 GBP | 0.78 | 62.25 | 27.5K | On |
| 19 Jun 2026 | 0.12 GBP | 0.0% | 0.07 GBP | 0.06 GBP | 0.90 | 65.66 | 1.1K | On |
| 12 Jun 2026 | 0.12 GBP | 0.0% | 0.07 GBP | 0.06 GBP | 1.12 | 65.49 | 78.9K | On |
| 5 Jun 2026 | 0.12 GBP | 0.0% | 0.07 GBP | 0.06 GBP | 1.38 | 68.91 | 1.3M | On |
| 29 May 2026 | 0.12 GBP | 0.0% | 0.06 GBP | 0.06 GBP | 1.35 | 69.34 | 1.8M | On |
| 22 May 2026 | 0.12 GBP | 2.1% | 0.06 GBP | 0.06 GBP | 1.25 | 70.23 | 3.5M | On |
| 15 May 2026 | 0.12 GBP | 94.2% | 0.06 GBP | 0.06 GBP | 1.07 | 72.89 | 7.1M | Off |
| 8 May 2026 | 0.06 GBP | 0.0% | 0.06 GBP | 0.06 GBP | 0.80 | -10.41 | 758.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.